USX:BGLC - BioNexus Gene Lab Corp

BioNexus Gene Lab Corp Common
Sector: Materials, Industry: Specialty Chemicals

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts
• Charts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized Adjust Display Metrics

Show %	2018 Q4	2019 Q1	2019 Q2	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	Graph
Insider Holdings (%)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	39.13% 0%	64.82% 65.6%	64.82% 0%	64.82% 0%	65.91% 1.7%	64.96% -1.4%	64.96% 0%	64.67% -0.4%	64.67% 0%	58.83% -9.0%	50.53% -14.1%	66.64% 31.9%
Net Margin	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	3.11% 0.6%	3.43% 10.4%	5.62% 64.1%	3.32% -40.9%	2.13% -35.8%	-0.97% -	-3.26% -	-4.3% -	-5.43% -	-29.92% -	-26.91% -	-27.25% -
Gross Margin	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	14.21% 1.6%	14.89% 4.8%	16.42% 10.2%	15.03% -8.5%	13.95% -7.2%	11.68% -16.3%	11.52% -1.4%	12.37% 7.4%	13.01% 5.1%	13.56% 4.3%	13.61% 0.3%	13.56% -0.3%
Operating Margin	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	5.21% 13.0%	5.98% 14.8%	7.9% 32.1%	5.78% -26.8%	3.81% -34.0%	0.29% -92.5%	-2.66% -	-3.66% -	-4.93% -	-28.76% -	-26.54% -	-26.82% -
Total Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	13.76M 16.9%	14.24M 3.5%	13.36M -6.2%	12.94M -3.1%	12.34M -4.7%	11.33M -8.1%	10.93M -3.6%	10.28M -6.0%	10.36M 0.8%	10.34M -0.2%	9.77M -5.5%	9.78M 0.0%
Total Assets	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	9.45M -4.6%	9.77M 3.4%	9.57M -2.0%	9.18M -4.2%	8.37M -8.8%	7.8M -6.8%	8.74M 12.1%	8.19M -6.3%	7.9M -3.5%	11.47M 45.2%	11.4M -0.6%	11.16M -2.1%
Total Liabilities	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	2.63M -15.2%	2.71M 3.0%	2.39M -11.7%	2.05M -14.5%	1.55M -24.4%	1.37M -11.1%	2.08M 51.0%	1.63M -21.5%	1.94M 18.7%	1.78M -8.1%	1.74M -2.0%	1.82M 4.3%
Total Equity	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	6.81M 0.3%	7.05M 3.5%	7.18M 1.8%	7.13M -0.7%	6.82M -4.3%	6.42M -5.8%	6.67M 3.8%	6.56M -1.6%	5.96M -9.0%	9.69M 62.4%	9.66M -0.3%	9.34M -3.2%
Operating CashFlow	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	867.33K -47.3%	458.64K -47.1%	9.16K -98.0%	-144.11K -	561.28K -	552.57K -1.6%	544.03K -1.5%	463.57K -14.8%	637.5K 37.5%	-570.74K -	-1.3M -	-1.22M -
Beginning Cash Position	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	1.29M -7.8%	2.19M 70.2%	2.79M 27.3%	2.47M -11.2%	1.48M -40.1%	1.7M 14.7%	2.12M 24.9%	1.84M -13.2%	1.34M -27.3%	1.46M 9.1%	2.12M 44.9%	1.97M -6.9%
End Cash Position	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	1.4M -40.2%	1.8M 28.0%	2.12M 18.2%	1.92M -9.6%	1.6M -16.9%	1.89M 18.3%	2.12M 12.3%	2.17M 2.2%	1.94M -10.5%	6.22M 221.1%	5.93M -4.7%	6.18M 4.2%
Free Cash Flow	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	444.55K -63.7%	35.44K -92.0%	6K -83.1%	-178.65K -	526.11K -	514.15K -2.3%	489.86K -4.7%	441.49K -9.9%	602.35K 36.4%	-736.23K -	-1.45M -	-1.39M -
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	427.3K 17.6%	488.17K 14.2%	751.57K 54.0%	429.89K -42.8%	262.97K -38.8%	-109.75K -	-355.97K -	-442.1K -	-562.69K -	-3.09M -	-2.63M -	-2.66M -
Diluted Net Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	427.3K 17.6%	488.17K 14.2%	751.57K 54.0%	429.89K -42.8%	262.97K -38.8%	-109.75K -	-355.97K -	-442.1K -	-562.69K -	-3.09M -	-2.63M -	-2.66M -
Diluted EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	0.049 14.4%	0.042 -13.7%	0.036 -14.8%	0.025 -30.0%	0.002 -92.9%	-0.024 -	-0.024 -	-0.037 -	-0.038 -	-0.272 -	-0.183 -	-0.194 -
Return On Equity (%)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	10.98% 18.3%	12.23% 11.4%	10.86% -11.2%	6.18% -43.1%	3.86% -37.5%	-1.63% -	-5.14% -	-6.46% -	-8.8% -	-38.4% -	-32.21% -	-33.5% -
Return On Assets (%)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	8.13% 23.4%	9.06% 11.4%	7.63% -15.7%	4.51% -41.0%	2.95% -34.5%	-1.25% -	-3.89% -	-5.09% -	-6.92% -	-32.12% -	-26.11% -	-27.53% -